Hallucinations have been classified based on sensory modalities in which they are perceived and on whether they are soothing ( ego-syntonic ) or distressing ( ego-dystonic ) to the patient. The question here is: If the patient undergoing treatment does not wish that certain hallucinations should go away and rather wants them to stay, is it ethically correct for clinicians to start pharmacotherapy and eliminate such symptoms that cause the patient solace while also providing him relief from the distressing symptoms.
Source: Annals of Indian Psychiatry
